Seproxetine
Seproxetine is a serotonin reuptake inhibitor (SRI) that was being developed by Eli Lilly and Company for the treatment of depression. It is the active metabolite of fluoxetine, a selective serotonin reuptake inhibitor (SSRI). Seproxetine was being developed as a "me too" drug for the indication of depression and had reached phase II clinical trials before development was discontinued.
Pharmacology[edit | edit source]
Seproxetine, like its parent compound fluoxetine, works by inhibiting the reuptake of serotonin in the brain, thereby increasing levels of this neurotransmitter available to bind to the post-synaptic receptor. It has been shown to be a potent and selective inhibitor of serotonin reuptake, making it a powerful antidepressant.
Development and Clinical Trials[edit | edit source]
Seproxetine was being developed by Eli Lilly and Company, the same company that developed fluoxetine. It had reached phase II clinical trials for the treatment of depression. However, development was discontinued for unknown reasons. It is speculated that the development was stopped due to the emergence of unexpected side effects during the trials, or due to strategic decisions within the company.
See Also[edit | edit source]
References[edit | edit source]
| Seproxetine Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
